Alzamend Neuro is a biopharmaceutical company developing treatments for neurodegenerative diseases and psychiatric disorders. It offers mutant-peptide immunotherapeutic AL002, for use as a treatment or vaccine, and a lithium-based ionic cocrystal therapy AL001, that reduces or eliminates the symptoms of agitation and other endpoints for mild to moderate stage patients diagnosed with Alzheimer’s disease.